The global gamma probe devices market is poised for remarkable growth, with a projected valuation of US$ 86.9 Million by the close of 2023, and an anticipated Compound Annual Growth Rate (CAGR) of 9.8%, propelling it to an impressive valuation of approximately US$ 244.3 Million by 2033. These insights are derived from a comprehensive study conducted by Future Market Insights.
The study highlights the prominence of trolley-mounted devices, emerging as the frontrunners in the market, commanding an expected market share of 38.7% in 2023. This indicates a significant market preference for these devices within the global landscape.
Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-10037
“We are witnessing a dynamic shift in the market landscape, and the robust growth trajectory is indicative of the increasing demand for trolley-mounted devices,” says, gamma probe devices market at Future Market Insights. “The versatility and efficiency offered by these devices have positioned them as leaders in the industry, catering to diverse applications across sectors.”
Sentinel node biopsy is used for determining if the tumor has metastasized or spread to newer places. Such biopsies happen to be common for staging melanoma and breast cancer; and are also turning out to be popular with regards to staging the other forms of cancer. The radionuclide or carrier substance like Nano colloid or technetium-99m or sestamibi are used in the form of tracer for the gamma probe device.
The IAEA (International Atomic Energy Agency) states that parathyroid detection is growing at an alarming rate with upcoming intraoperative usage of gamma probes for direct detection of tumor.
The World Cancer Research Fund International confirms that breast cancer is amongst the most common cancer at the global level in the females and second-seeded of all, with over 2000K novel cases getting diagnosed every single year. These figures are expected to take the gamma probe devices market by storm in the upcoming period.
The ongoing trend is that of launching click-on gamma probe; which is seen as a healthy step toward 100% integration of radio guidance on the count of surgery. The DROP-IN (tethered) gamma-probe concept facilitates detector to match levels of freedom of robotic instruments as well as enables autonomous control by operating surgeon.
At the same time, higher installation and maintenance costs linked with gamma probe devices are bound to hamper the gamma probe devices market in the forecast period.
Future Market Insights has entailed these facts with future perspectives in its latest market study entitled ‘Gamma Probe Devices Market’. It has its team of analysts and consultants to look through, with 360-degree view across macros and micros.
Key Takeaways from Gamma Probe Devices Market:
- North America holds a significant market share with the US being subject to concentration on improvising on flexibility, throughput, and productivity. Nuclear therapies’ frequency is increasing due to remarkable investments in research on this count.
- Europe stands second with Germany leading from the front. This could be credited to well-established players being present over here along with rising spending on healthcare.
- The Asia-Pacific is expected to grow at a rapid pace in the gamma probe devices market in the forecast period with China dominating the scene. This could be reasoned with growing frequency of chronic ailments.
Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-10037
Competitive Devices:
- Southern Scientific, in October 2021, entered into collaboration with Helgeson. The latter comes across as a producer of various detectors, equipment, and area monitors with more than 3 decades of experience in nuclear therapy.
- KUBTEC, in May 2022, did acquire Wprobe Technology from ‘Oncovision’s firm’. The technology is looked upon as a gold standard in the radio-guided surgery and does involve a spectrum of wireless gamma probes to identify sentinel lymph node.
- Lightpoint Medical, in February 2022, did report that Dr. Doug Adams (one of the specialists in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio)) performed the first of its kind lung procedure with SENSEI (new miniature robotic gamma probe).
What does the Report probe?
- The research study is based on modality (handheld device, benchtop device, and trolley mounted device), by application (thyroid uptake and sentinel lymph node uptake (breast cancer, melanoma, colon cancer, NSCLC, renal cancer, and others), and by end-user (hospitals, ASCs (Ambulatory Surgical Centers), and specialty centers and clinics).
- With growing awareness regarding advantages of gamma radiation over traditional detection methods such as X-Rays, the global gamma probe devices market is expected to stand in a good stead in the near future.
Key Companies Covered:
- Biodex Medical Systems, Inc.
- CAPINTEC, INC.
- Crystal Photonics GmBH
- Devicor Medical Products, Inc (Mammotome)
- Dilon Technologies, Inc
- Gamma Medical Technology
- Intramedical Imaging
- Intramedical Imaging
- KUB Technologies
- L’ACN – l’Accessorio Nucleare
- Mammotome
- NUCLEAR MEDSYSTEMS
- Oncovision
- Southern Scientific Ltd.
Discover the Future of Marketing: Get Your Hands on Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-10037
Key Market Segments Covered in Gamma Probe Devices Industry Research:
Modality:
- Hand Held Device
- Benchtop Device
- Trolley Mounted Device
Application:
- Thyroid Uptake
- Sentinel Lymph Node Uptake
- Breast Cancer
- Melanoma
- Colon Cancer
- NSCLC
- Renal Cancer
- Others
End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Centers and Clinics
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
